The Research and Scientific Team at Resistance focuses on advancing our understanding of treatment-resistant cancer. This team conducts pre-clinical studies to discover novel therapeutic targets and develop strategies to overcome resistance to existing treatments, driving innovations that enhance patient outcomes.